Recognizing thrombotic thrombocytopenic purpura (TTP) in a woman with lupus and starting combined treatment — Cablivi (caplacizumab) on top of plasma exchange, corticosteroids,…
News
Use of the experimental cell therapy QT-019B showed promise for people with treatment-resistant immune thrombocytopenia (ITP) in early clinical testing, restoring platelet counts —…
Doctors successfully treated a large and painful muscle bleed in a 32-year-old woman with von Willebrand disease (VWD) using a minimally invasive approach: a…
The cases of adult siblings in Israel, both diagnosed with infantile-onset acquired thrombotic thrombocytopenic purpura (TTP) as children, led to the discovery of a…
Electrical stimulation of nerves that control automatic bodily functions, administered twice daily through a device worn over the ear, may help control heavy menstrual bleeding…
Most people with the rare blood disorder immune-mediated thrombotic thrombocytopenic purpura (iTTP) recover well after admission to the intensive care unit (ICU), and treatment with…
Scientists in China have discovered that the proteins RNF5 and DNAJC21 — the latter encoded by the DNAJC21 gene — may be useful targets for…
A woman with the rare blood disorder congenital thrombotic thrombocytopenic purpura (TTP) safely underwent hip replacement surgery while being treated with Adzynma (ADAMTS13…
Researchers have developed two novel antibody-based therapies that may be used to treat antibody-mediated autoimmune diseases such as immune thrombocytopenia (ITP), according to a…
Seragene Therapeutics has received funding from Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), to advance the…
